Merle Breeding Liability: What Courts and Veterinary Testimony Now Expect
Over the past five years, a quiet shift has occurred in how courts in several English-speaking jurisdictions treat litigation arising from double merle breedings. Buyer claims that would have been dismissed as mere disappointment in the 1990s are now being supported by expert veterinary testimony, veterinary medical record subpoenas, and increasingly sophisticated genetic evidence. Breeders who produce double merle puppies — whether through ignorance, carelessness, or deliberate action — are now facing real financial and sometimes criminal consequences. This article reviews where the liability landscape has moved, what expert testimony now considers the standard of care, and what documentation protects breeders acting in good faith.

The Standard of Care Has Shifted
When a case involving a double merle puppy reaches the point of expert veterinary testimony, the question I am most often asked is straightforward: what should a competent breeder have known and done before this breeding occurred? Ten years ago, my answer acknowledged that genetic testing was emerging and not universally expected. Today, the answer is much sharper.
For any breed where merle is present, the current standard of care expected by veterinary expert witnesses in civil proceedings includes genetic testing of both prospective sire and dam for the SILV/PMEL17 variants, documentation of those results including allele lengths, visual and genetic assessment for cryptic merle carriers, and written records of the breeding decision rationale. Breeders who cannot produce this documentation are in a difficult position when their produced puppies develop the ocular and auditory abnormalities characteristic of homozygous merle-merle genotypes.
What Plaintiffs Typically Argue
The claims I have seen succeed in civil actions share common structural elements:
- Breach of implied warranty of merchantability. The puppy was not fit for the ordinary purpose of companionship, display, or working function due to congenital defects the breeder could have prevented.
- Negligent misrepresentation. The breeder represented the puppy or the breeding as appropriate, when reasonable diligence would have identified the merle-merle risk.
- Failure to meet the standard of care of a prudent breeder. Expert testimony establishes that competent breeders in the jurisdiction perform genetic testing before merle-relevant breedings.
- Consumer protection statute violations. Increasingly, jurisdictions with specific puppy sale consumer protection laws include health testing as part of the mandatory disclosure framework.
The damages in these cases can be substantial. They include purchase price refunds, ongoing veterinary care costs for conditions that will last the puppy's lifetime, specialist consultations, and in some jurisdictions pain and suffering awards for the emotional impact on the buyer. Specialist ophthalmology and audiology bills alone can exceed $10,000 over a double merle puppy's life. See the related clinical overview at the comprehensive medical guide to double merle health for the full range of conditions typically cited.
Veterinary Expert Testimony in Practice
When I have served as an expert witness in these proceedings, the questions I receive from counsel on both sides have become more sophisticated. Plaintiffs' counsel asks about:
- The year at which genetic testing for the SILV variant became reasonably available
- The published breeder guidelines that existed at the time of the breeding
- What a reasonable breeder in the jurisdiction would have known about allele instability and cryptic carriers
- Whether the offered testing was appropriate for the specific breed and its allele distribution
Defense counsel, for their part, has become more sophisticated about the limits of genetic prediction. A responsible breeder who tested both dogs, received clear results, and still produced a double merle due to documented allele length instability is in a meaningfully different legal position from a breeder who never tested at all. The mechanism of merle allele instability matters legally because it establishes that even good-faith compliance with the standard of care does not eliminate all risk — which is what separates a defensible outcome from negligence.
Documentation That Protects Breeders
The breeders I have seen weather legal challenges successfully share consistent documentation habits:
- Pre-breeding genetic test results with dated certificates from accredited laboratories
- Written breeding plan acknowledging the merle status of both parents and the rationale
- Photographic records of puppies at birth, at regular intervals, and at placement
- Veterinary examinations of puppies before placement, with specific ophthalmic and auditory findings noted
- Written contracts acknowledging the buyer's informed consent when any genetic risk exists
- Correspondence with buyers about the breed's genetic considerations before sale
The contract question is particularly important. A well-drafted contract that truthfully discloses the parent dogs' genetic status, explains the implications, and evidences the buyer's informed acceptance of any residual risk provides substantially more legal protection than a generic purchase agreement. Combined with the pre-placement veterinary examination documentation recommended in our puppy health screening protocol, this forms the documentation core that competent expert testimony cannot easily undermine.
Criminal Exposure
In most jurisdictions, double merle breedings resulting in affected puppies remain civil rather than criminal matters. However, in jurisdictions with animal welfare statutes that cover breeding practices specifically — which increasingly includes the United Kingdom under various welfare regulations, several European jurisdictions, and some US states — deliberate merle-to-merle breeding with known affected status can attract welfare-related enforcement action in addition to civil liability. The overview of merle-relevant legislation and kennel club policies summarizes the current regulatory picture.
The Bottom Line for Breeders
The liability landscape has moved, and it has moved in one direction. Competent breeders who test, document, and make informed decisions continue to practice without meaningful legal exposure. Breeders who produce affected puppies without evidence of reasonable diligence increasingly find that expert testimony will not support them, that courts now understand the relevant genetics, and that buyers have meaningful paths to compensation.
This is, from my perspective as a canine geneticist who cares about breed welfare, a positive development. The legal system is catching up to what the veterinary profession has understood for decades about merle breeding genetics. Breeders who meet the current standard of care protect themselves legally while protecting the puppies they produce. That alignment between welfare and legal risk is, finally, where it should be.